Dual inhibition of RAF/MEK/ERK and PI3K/PDK/AKT signaling pathways with small molecules as anti-canc

来源 :2015年全国药物化学学术会议暨第五届中英药物化学学术会议 | 被引量 : 0次 | 上传用户:yxl122702985
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  RAF/MEK/ERK pathways and PI3K/PDK/AKT pathways are involved in the regulation of cell growth and survival and are frequently dysregulated in human cancers,such as leukemia,melanoma and lung cancer.
其他文献
会议
Multidrug resistance(MDR)is a major obstacle that leads to most tumor treatment failures.Thus,it is imperative to develop new approach and design new chemotherapy to overcome this challenge.Recently,t
糖尿病是当前威胁全球人类健康的最重要的慢性非传染性疾病之一.根据国际糖尿病联盟(IDF)的最新统计,2014年全球糖尿病患者人数已达3.87亿,且到2035年估计将有5.92亿病例,而目前中国成人糖尿病患者数量预计已超过1亿,居全球首位.因此,治疗糖尿病的新型药物的研发是全球关注的热点之一.
Microbial infections endanger public health unremittingly and cause a huge economic burden to our society.Numerous efforts have been made to develop molecules which are able to inhibit pathogens.Novel
会议
会议
会议
Increased generation of reactive oxygen species(ROS)and an altered redox status have long been observed in cancer cells,and recent studies suggest that this biochemical property of cancer cells can be
Blockade of the protein-protein interaction between the transmembrane programmed cell death 1 protein(PD-1)and its ligand PD-L1 emerges as a promising immunotherapy for treating cancers.Using the tech
Docking-based virtual screening of chemical databases against macromolecular targets has identified bioactive compounds for the potential treatment of diseases.Because of the restriction of scoring fu